drug
NOREPINEPHRINE BITARTRATE
Marketedupdated 3mo agoby Inforlife SA
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- drugNOREPINEPHRINE BITARTRATE IN 5% DEXTROSE34 co-mentions · 13 sources
- drugNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE34 co-mentions · 13 sources
- drugNorepinephrine Bitartrate Baxter34 co-mentions · 13 sources
- drugnorepinephrine34 co-mentions · 13 sources
- tagApproval32 co-mentions · 9 sources
- drugRNS-6018 co-mentions · 10 sources
- tagRecall4 co-mentions · 4 sources
all catalysts(8)
approval · 8
Jan 15, 2021
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Jun 2, 2022
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Jun 2, 2022
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Nov 23, 2023
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Jun 11, 2024
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Dec 11, 2025
approval
NOREPINEPHRINE BITARTRATE — FDA approval
NOREPINEPHRINE BITARTRATE
→
Feb 6, 2026
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Mar 26, 2026
approval
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 26, 2035
~8.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (36)
- Mar 8, 2041formulationUS 12097170
- Mar 8, 2041formulationUS 12097170
- Mar 8, 2041formulationUS 12097170
- Mar 8, 2041formulationUS 12290494
- Mar 8, 2041formulationUS 12290494
- Apr 26, 2039formulationUS 10888534
- Apr 26, 2039formulationUS 10888534
- Apr 26, 2039formulationUS 10888534
- Apr 26, 2039formulationUS 10888534
- Jan 30, 2038formulationUS 10159657
- Jan 30, 2038formulationUS 10159657
- Jan 30, 2038formulationUS 10159657
- Jan 30, 2038formulationUS 10226436
- Jan 30, 2038formulationUS 10226436
- Jan 30, 2038formulationUS 10226436
- Jan 30, 2038formulationUS 10420735
- Jan 30, 2038formulationUS 10420735
- Jan 30, 2038formulationUS 10420735
- Jan 30, 2038formulationUS 10568850
- Jan 30, 2038formulationUS 10568850
- Jan 30, 2038formulationUS 10568850
- Jan 30, 2038formulationUS 11413259
- Jan 30, 2038formulationUS 11413259
- Jan 30, 2038formulationUS 11413259
- Jan 30, 2038formulationUS 11602508
- Jan 30, 2038formulationUS 11602508
- Jan 30, 2038formulationUS 11602508
- Jan 30, 2038formulationUS 12245996
- Jan 30, 2038formulationUS 12245996
- Jan 30, 2038formulationUS 12245996
- Feb 26, 2035formulationUS RE49422
- Feb 26, 2035formulationUS RE49422
- Feb 26, 2035formulationUS RE49422
- Feb 26, 2035formulationUS RE49422
- Feb 26, 2035formulationUS RE49443
- Feb 26, 2035formulationUS RE49443
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that